Company news

PureTech Health PLC news in 2024

PureTech Health PLC's news releases, calls and decks from 2024, newest first.

View company

PRTC's Ph2b in IPF Successful; New SOC Potential

December 16, 2024

PRTC's Seaport Presents Ph1 SPT-300 Data at ACNP

December 11, 2024

PRTC Presents LYT-200 Phase 1b Data in AML at ASH

December 9, 2024

PRTC's Seaport Adds Microsoft and J&J Exec to BOD

November 20, 2024

PRTC's Seaport Adds Biotech Finance Exec as CFO

November 5, 2024

Director/PDMR Shareholding

October 31, 2024

PRTC to Present at UBS and Jefferies Conferences

October 30, 2024

PRTC's Seaport Closes $225M Series B Financing

October 21, 2024

PRTC's IPF Patient Research & Ph 2b On Track YE24

October 9, 2024

PRTC to Give 3 Presentations at CHEST 2024 Meeting

October 1, 2024

KarXT/Cobenfy Approved by FDA; PRTC Receives $29M

September 27, 2024

PRTC's Vor Shares New AML Data Validating Approach

September 6, 2024

Results of AGM on 13 June 2024 – Update Statement

August 28, 2024

PRTC Adds Industry Leader to Board of Directors

August 22, 2024

PRTC's Seaport Appoints Global Pharma Exec to BOD

August 13, 2024

PRTC'S Vedanta Expands Leadership Team

July 23, 2024

Completion of Tender Offer & Total Voting Rights

June 24, 2024

Result of Tender Offer

June 24, 2024

Director Declaration

June 20, 2024

PRTC's Seaport Appoints Seasoned Execs to Team

June 18, 2024

Result of Meeting

June 6, 2024

Additional Disclosure Re: Tender Offer

June 4, 2024

PRTC's Akili Enters Into Merger Agreement

May 29, 2024

PRTC's Vedanta Begins Phase 3 of VE303 in C. diff

May 21, 2024

Tender Offer

May 20, 2024

PRTC's Seaport Presents Ph1 and Ph2a SPT-300 Data

May 9, 2024

PRTC's Seaport Announces Board/Team Appointments

May 7, 2024

PRTC LYT-100 Ph2b in IPF Enrolled; Results Q4 2024

April 16, 2024

FDA Grants PRTC's LYT-200 Fast Track Designation

April 11, 2024

PRTC Launches Seaport w/ $100M; Leadership Changes

April 9, 2024

$100M Tender Offer

March 19, 2024

$14B Acquisition of PRTC’s Karuna by BMS Completed

March 18, 2024

FDA Grants PRTC's LYT-200 Orphan Drug Designation

March 13, 2024

PRTC to Present at Cowen and Leerink Conferences

February 27, 2024

PRTC: Akili Positive Ph3 & Japan PMDA Submission

February 27, 2024

Transaction in Own Shares

February 8, 2024

PureTech to present at the JP Morgan Conference

January 3, 2024